Fungal cell wall vaccines: an update.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

26 citing papers in PubMed, 66 citations in OpenAlex.

1. Dendritic Cell-Based Therapeutic Immunization Induces Th1/Th17 Responses and Reduces Fungal Burden in Experimental Sporotrichosis.Microorganisms · 2025
   Article
2. Immunoinformatic-guided designing and evaluating protein and mRNA-based vaccines against Cryptococcus neoformans for immunocompromised patients.Journal, genetic engineering & biotechnology · 2023
   Article
3. Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine.Frontiers in immunology · 2022
   Article
4. Prophylaxis and Therapeutic Ability of Inactivated Dermatophytic Vaccine Against Dermatophytosis in the Rabbits as an Animal ModelTurkish journal of pharmaceutical sciences · 2021
   Article
5. Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections.Frontiers in microbiology · 2021
   Review
6. Vaccine-Induced Immunological Memory in Invasive Fungal Infections - A Dream so Close yet so Far.Frontiers in immunology · 2021
   Review
7. Advances in Fungal Peptide Vaccines.Journal of fungi (Basel, Switzerland) · 2020
   Review
8. A Recombinant Enolase-Montanide™ PetGel A Vaccine Promotes a Protective Th1 Immune Response against a Highly VirulentPharmaceutics · 2019
   Article
9. Transcriptomic and Genomic Approaches for UnravellingGenes · 2018
   Review
10. Journal of fungi (Basel, Switzerland) · 2018
    Article
11. The antifungal pipeline: a reality check.Nature reviews. Drug discovery · 2017
    Review
12. Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis.Frontiers in microbiology · 2017
    Review
13. Immunobiological Activity of Synthetically Prepared Immunodominant Galactomannosides Structurally MimickingFrontiers in immunology · 2017
    Article
14. Methods of Controlling Invasive Fungal Infections Using CD8Frontiers in immunology · 2017
    Review
15. Beta-glucan contamination of pharmaceutical products: How much should we accept?Cancer immunology, immunotherapy : CII · 2016
    Review
16. 6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.ACS infectious diseases · 2016
    Article
17. New insights on the development of fungal vaccines: from immunity to recent challenges.Memorias do Instituto Oswaldo Cruz · 2015
    Review
18. Studies of Immune Responses in Candida vaginitis.Pathogens (Basel, Switzerland) · 2015
    Review
19. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.mBio · 2015
    Article
20. A Convergent Synthesis of 6-European journal of organic chemistry · 2015
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author at 1 institution in 1 country.

Funding

Abstract

Indexed as